BSECompany Update10 Aug 2026 · 10 Aug 2026, 03:07 pm
Newspaper Publication
Akums Drugs and Pharmaceuticals Ltd · 544222
✦ AI SummaryResults
Akums Drugs and Pharmaceuticals Ltd has published un-audited financial results for the quarter ended June 30, 2026, as approved by the Board of Directors on August 08, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Akums Drugs and Pharmaceuticals Ltd - 544222 - Newspaper Publication
Attachments (1)
📄pdf
Download →
98f4b10c-4cdb-4669-b39e-0b5a390d2439.pdf
View document text
Ref: Akums/Exchange/2026-27/41 August 10, 2026
To, To,
The Listing Department The Listing Department
National Stock Exchange of India Ltd. BSE Limited
Exchange Plaza, C-1, Block G, 25th Floor, New Trading Ring,
Bandra Kurla Complex, Rotunda Building, Phiroze Jeejeebhoy
Bandra (E), Mumbai – 400 051 Towers, Dalal Street, Mumbai – 400 001
Symbol: AKUMS Scrip Code: 544222
Sub: Newspaper Publication
Respected Sir/Ma’am,
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, please find enclosed herewith copies of the newspaper advertisements
published on August 09, 2026 in the following newspapers:
1. Financial Express (English – New Delhi Edition)
2. Jansatta (Hindi – New Delhi Edition)
The advertisements contain a Quick Response (QR) Code enabling direct access to the un-
audited (Standalone & Consolidated) Financial Results of Akums Drugs and Pharmaceuticals
Limited (“the Company”) for the quarter ended June 30, 2026 as approved by the Board of
Directors at its meeting held on August 08, 2026.
A copy of this disclosure is being updated on the website of the Company at www.akums.in
This is for your kind information and records.
Thanking You
Yours Faithfully
For Akums Drugs and Pharmaceuticals Limited
Dharamvir Malik
Company Secretary & Compliance Officer
Encl.: As Above